Cystatin C associates with arterial stiffness in older adults

Journal of the American Society of Nephrology

Volumn 20, Issue 5, 2009, Pages 1086-1093

  Madero, Magdalena ^a   Wassel, Christina L ^b   Peralta, Carmen A ^b   Najjar, Samer S ^d   Sutton Tyrrell, Kim ^e   Fried, Linda ^f   Canada, Robert ^g   Newman, Anne ^e   Shlipak, Michael G ^b,c   Sarnak, Mark J ^h  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; BIOLOGICAL MARKER;

AGED; ARTERIAL STIFFNESS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PULSE WAVE; ARTERY; BLOOD; BLOOD FLOW VELOCITY; BODY COMPOSITION; CARDIOVASCULAR DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PULSE RATE; RISK FACTOR;

AGED; ARTERIAL OCCLUSIVE DISEASES; ARTERIES; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BODY COMPOSITION; CARDIOVASCULAR DISEASES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; PERIPHERAL VASCULAR DISEASES; PULSE; RISK FACTORS;

EID: 65649112559     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008030318     Document Type: Article

References (34)

1. Konings CJ, Hermans M, Kooman JP, Meinders JM, Hoeks AP, van der Sande FM, Leunissen KM: Arterial stiffness and renal replacement therapy. Perit Dial Int 24: 318-322, 2004 (Pubitemid 39206625)
2. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548-1555, 2002
3. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM: Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 63: 1852-1860, 2003 (Pubitemid 36513333)
4. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG, Cardiovascular Health Study: Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142: 497-505, 2005 (Pubitemid 40490915)
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004 (Pubitemid 39268908)
6. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049-2060, 2005 (Pubitemid 40664306)
7. Fliser D, Ritz E: Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 37: 79-83, 2001 (Pubitemid 32055022)
8. Mourad JJ, Girerd X, Boutouyrie P, Laurent S, Safar M, London G: Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 30: 1425-1430, 1997 (Pubitemid 27528085)
9. Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ: Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: A study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19: 2307-2312, 2004 (Pubitemid 39214126)
10. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001 (Pubitemid 34258697)
11. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM, Safar ME: Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59: 1834-1841, 2001 (Pubitemid 32336798)
12. Ohya Y, Iseki K, Iseki C, Miyaqi T, Kinjo K, Takishita S: Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis 47: 790-797, 2006
13. Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, Froissart M, Houillier P, Boutouyrie P: Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 69: 350-357, 2006 (Pubitemid 43323087)
14. Finney H, Newman DJ, Thakkar H, Fell JM, Price CP: Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Intern Med 82: 71-75, 2000 (Pubitemid 30305737)
15. Norlund L, Fex G, Lanke J, Von Schenck H, Nilsson JE, Leksell H, Grubb A: Reference intervals for the glomerular filtration rate and cell-proliferation markers: Serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest 57: 463-470, 1997 (Pubitemid 27443517)
16. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416-1421, 2004 (Pubitemid 38406982)
17. Manetti L, Pardini E, Genovesi M, Campomori A, Grasso L, Morselli LL, Lupi I, Pellegrini G, Bartalena L, Bogazzi F, Martino E: Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 28: 346-349, 2005 (Pubitemid 43162754)
18. Risch L, Herklotz R, Blumberg A, Huber AR: Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 47: 2055-2059, 2001 (Pubitemid 33010731)
19. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, Kusek JW, Beck GJ, Collins AJ, Levey AS, Sarnak MJ: Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 147: 19-27, 2007
20. Safar ME, Thuilliez C, Richard V, Benetos A: Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res 46: 269-276, 2000 (Pubitemid 30204599)
21. Brooks VL, Scrogin KE, McKeogh DF: The interaction of angiotensin II and osmolality in the generation of sympathetic tone during changes in dietary salt intake: An hypothesis. Ann N Y Acad Sci 940: 380-394, 2001
22. Safar ME, London GM, Plante GE: Arterial stiffness and kidney function. Hypertension 43: 163-168, 2004
23. Amann K, Neususs R, Ritz E, Irzyniec T, Wiest G, Mall G: Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 8: 409-417, 1995
24. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE: Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44: 1024-1030, 2004 (Pubitemid 39556482)
25. Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF: Cystatin C and mortality risk in the elderly: The Health, Aging, and Body Composition Study. J Am Soc Nephrol 17: 254-261, 2006
26. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
27. Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD, Hoorn Study: Arterial stiffness increases with deteriorating glucose tolerance status: The Hoorn Study. Circulation 107: 2089-2095, 2003 (Pubitemid 36532189)
28. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, Ishimura E, Tabata T, Nishizawa Y: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12: 2117-2124, 2001 (Pubitemid 32880348)
29. Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G: Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol 16: 1069-1075, 2005 (Pubitemid 41710317)
30. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A; Health ABC Study: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111:3384-3390, 2005 (Pubitemid 40923391)
31. Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59: 1-8, 1999 (Pubitemid 29133539)
32. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
33. National Kidney Foundation Kidney Disease Outcomes Quality Initiative: Evaluation, classification and stratification. Am J Kidney Dis 39: 784-795, 2002
34. Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, Solomon SD, Domanski MJ, Jablonski KA, Rice MM, Pfeffer MA, Prevention of Events with Angiotensin-Converting Enzyme Inhibition Investigators: Long-term trandolapril treatment is associated with reduced aortic stiffness: The prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 49:1271-1277, 2007